Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 17, 2024 07:00 ET | Source: Ancilia Biosciences

Ancilia Biosciences Announces Closing of $4.2 Million Financing

Ancilia raised $4.2M to leverage CRISPR’s natural function to create bacterial therapies with immunity against the viruses that limit their effectiveness.